PHASE 1 STUDY OF ULTRA-HIGH CONCENTRATION NITRIC OXIDE ABLATION IN RELAPSED OR REFRACTORY, UNRESECTABLE, PRIMARY, OR METASTATIC CUTANEOUS AND SUBCUTANEOUS MALIGNANCIES

Category Primary study
JournalJournal for ImmunoTherapy of Cancer
Year 2023
This article has no abstract
Epistemonikos ID: e4c3d654c933c2b0ff767bf72c5e8ff762989891
First added on: Feb 17, 2025